Modulation of ion channels by macromolecular signaling complexes and phosphorylation plays an important role in the regulation of excitation-contraction (E-C) coupling. In cardiac myocytes, the L-type Ca2+ channel (Cav1.2) current (ICa), the major depolarizing current contributing to the plateau of the action potential and E-C coupling, is highly regulated by hormones, in large part through the activation of protein kinases and phosphatases. It is well established that Cav1.2 plays a key role in modulating cardiac function in response to classical signaling pathways, such as the renin-angiotensin system (RAS) and sympathetic nervous system (SNS). Treatment of several major cardiovascular diseases is dependent, in part, upon the modulation of these pathways by drugs. This proposal focuses on gaining a better understanding of the mechanisms by which a major cardiac protein kinase, protein kinase C (PKC), which is activated by the RAS and SNS, modulates the function of Cav1.2. We have mapped critical PKC phosphorylation sites on the Cav1.2 alpha1c and beta2 subunits and have prepared phospho-peptide specific antibodies;each uniquely designed to recognize only a single phosphorylated Cav1.2 channel site. Our preliminary data suggest that the different cardiac PKC isoforms can phosphorylate distinct Cav1.2 sites in vitro. Utilizing the phospho-peptide and site specific antibodies, the applicant proposes to study the role of different PKC isoforms in the modulation of Cav1.2 in normal and pathological hearts.
Three specific aims are proposed: (1) To characterize biochemically and pharmacologically the phosphorylation of Cav1.2 in cells, tissues and animals;(2) To characterize electrophysiologically PKC modulation of cardiac Cav1.2;(3) To characterize the PKC modulation of Cav1.2 in heart failure and hypertrophy. Utilizing biochemical, molecular biological, and electrophysiological techniques, we will explore the molecular mechanisms and cellular signaling pathways impinging upon Cav1.2 regulation in normal and diseased hearts. Electrophysiological characterization of the effects of PKC phosphorylation of specific Cav1.2 residues will be carried out in heterologous expression systems and cardiomyocytes. Since heart failure and hypertrophy are associated with alterations in PKC activity and Ca2+ homeostasis, understanding the PKC modulation of Cav1.2 may contribute to the development of novel therapeutic agents to treat these disorders.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Electrical Signaling, Ion Transport, and Arrhythmias Study Section (ESTA)
Program Officer
Przywara, Dennis
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Yang, Lin; Katchman, Alexander; Samad, Tahmina et al. (2013) ?-adrenergic regulation of the L-type Ca2+ channel does not require phosphorylation of ?1C Ser1700. Circ Res 113:871-80
Wu, Roland S; Liu, Guoxia; Zakharov, Sergey I et al. (2013) Positions of ?2 and ?3 subunits in the large-conductance calcium- and voltage-activated BK potassium channel. J Gen Physiol 141:105-17
Yang, Lin; Katchman, Alexander; Morrow, John P et al. (2011) Cardiac L-type calcium channel (Cav1.2) associates with gamma subunits. FASEB J 25:928-36
Morrow, John P; Katchman, Alexander; Son, Ni-Huiping et al. (2011) Mice with cardiac overexpression of peroxisome proliferator-activated receptor ? have impaired repolarization and spontaneous fatal ventricular arrhythmias. Circulation 124:2812-21
Wu, Roland S; Marx, Steven O (2010) The BK potassium channel in the vascular smooth muscle and kidney: ýý- and ýý-subunits. Kidney Int 78:963-74
Liu, Guoxia; Niu, Xiaowei; Wu, Roland S et al. (2010) Location of modulatory beta subunits in BK potassium channels. J Gen Physiol 135:449-59
Doshi, Darshan; Marx, Steven O (2009) Ion channels, transporters, and pumps as targets for heart failure therapy. J Cardiovasc Pharmacol 54:273-8
Wu, Roland S; Chudasama, Neelesh; Zakharov, Sergey I et al. (2009) Location of the beta 4 transmembrane helices in the BK potassium channel. J Neurosci 29:8321-8
Chung, David Y; Chan, Priscilla J; Bankston, John R et al. (2009) Location of KCNE1 relative to KCNQ1 in the I(KS) potassium channel by disulfide cross-linking of substituted cysteines. Proc Natl Acad Sci U S A 106:743-8
Yang, Lin; Doshi, Darshan; Morrow, John et al. (2009) Protein kinase C isoforms differentially phosphorylate Ca(v)1.2 alpha(1c). Biochemistry 48:6674-83

Showing the most recent 10 out of 17 publications